Supplementary Data from Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer

Authors :: Jennifer R. Diamond
E. Jane Leonard
Rachel Neuwirth
Chirag Patel
Kevin J. Galinsky
Brittany Bahamon
Sylvie Vincent
Elizabeth Tan-Chiu
Hugues Bourgeois
Alain Lortholary
Michael Danso
Jean-Luc Canon
Ahmad Awada
Frederic Forget
Tufia C. Haddad
Paula Silverman
Mohamad A. Salkeni
David A. Potter
Bora Lim
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Material containing Supplementary Methods, 5 Supplementary Figures, and 8 Supplementary Tables

Tools